announced it was now offering prescriptions for Eli Lilly’s obesity drug Zepbound, which is a little amusing because of how much time and money Hims has spent railing against big pharma. But where a number of telehealth companies are providing access to vials of the branded drug through official partnerships, this appears to be something else. Lilly was quick to disavow any...
Category: <span>News</span>
Post
The differences between men’s and women’sheartsAdobe
Heart attacks look different in women — rather than clutching their chests, as men stereotypically do, they may experience more diffuse pain shooting through their jaw, neck, arm, back, and stomach. That’s just one of the myriad sex and gender differences in cardiovascular disease that researchers have discovered, from risk factors to the number and function of...
Post
Lilly to connect patients to telehealth providers of Alzheimer’s care
Eli Lilly is expanding its direct-to-consumer telehealth platform, LillyDirect, to include care for Alzheimer’s disease. It’ll connect patients with Synapticure, another telehealth company, which will arrange for virtual diagnoses and care navigation — but not drug delivery, since treatments like Lilly’s new infusion drug Kisunla require in-person administration. Lilly is framing this as an effort to streamline...
Post
HHS announces sweeping reorganization, including cuts of 10K workers
Along with shrinking the HHS’ workforce further, the reorganization announced Thursday will cut the department from 28 divisions to 15 and close five regional offices. DOJ backs up providers in suit against Claritev Claritev, formerly known as MultiPlan, is being accused of conspiring with insurers to lower reimbursement for providers. The DOJ agrees, filing a statement of...
Post
Meet the guy who’ll lead the federal study on vaccines and autism
You may not have heard of David Geier, but news that he was hired by HHS to conduct a federal study on immunizations and autism has been met with dropped jaws among vaccine experts, STAT’s Helen Branswell reports. “My first thought was … is this a hoax?” British investigative journalist Brian Deer said to Helen.Geier...
Post
Data du jour: Avoidable deaths
By Tina Reed Data: JAMA Internal Medicine; Chart: Axios VisualsAvoidable mortality rose across every U.S. state between 2009 and 2019, jumping about 25 deaths per 100,000 people across states over that time frame, according to a study published Monday in JAMA Internal Medicine.Why it matters: At the same time, many of America’s peer nations in the European Union (EU)...
Post
A big sign drug pricing changes are coming
Illustration: Allie Carl/Axios The America First Policy Institute — the think tank founded and staffed by Trump officials to advance his vision for the country — has written a new paper making the case against what it calls pharmaceutical “global freeloading” and outlining various policy measures to address it.Why it matters: The policy paper — well-timed to the political moment...
Post
New policies could worsen intersex health care
Adobe Kimberly Zieselman was born intersex. You may not have heard of intersex traits — variations in someone’s sex anatomy that don’t align with binary categories of female or male — but they’re as common as red hair, green eyes, and more common than identical twins. “We have always been here,” Zieselman writes in a new...
Post
one small number
1 in 10 That’s how many non-surgical, non-invasive treatment methods actually work when it comes to lower back pain — and even those that work only have a small effect. That’s according to a systematic review of 301 randomized controlled trials testing treatments for acute and chronic lower back pain, published yesterday in BMJ Evidence Based...
Post
UnitedHealth braces for Medicare Advantage scrutiny By Caitlin Owens Illustration: Allie Carl/Axios UnitedHealth Group is bracing for scrutiny from the Trump administration over the way it and other Medicare Advantage insurers bill the government, along with other cost-related topics, an executive at the health company told Axios.Why it matters: Mehmet Oz’s characterization of the Medicare Advantage system as “upside...